title: Role of cytochrome P-450 in reperfusion injury of the rabbit lung.
abstract: Reactive oxygen species are a major cause of damage occurring in ischemic tissue after reperfusion. During reperfusion transitional metals such as iron are required for reactive oxygen species to mediate their major toxic effects. Xanthine oxidase is an important source of reactive oxygen species during ischemia-reperfusion injury, but not in all organs or species. Because cytochrome P-450 enzymes are an important pulmonary source of superoxide anion (O2-.) generation under basal conditions and during hyperoxia, and provide iron catalysts necessary for hydroxyl radical (.OH) formation and propagation of lipid peroxidation, we postulated that cytochrome P-450 might have a potential role in mediating ischemia-reperfusion injury. In this report, we explored the role of cytochrome P-450 enzymes in a rabbit model of reperfusion lung injury. The P-450 inhibitors 8-methoxypsoralen, piperonyl butoxide, and cimetidine markedly decreased lung edema from transvascular fluid flux. Cimetidine prevented the reperfusion-related increase in lung microvascular permeability, as measured by movement of 125I-albumin from the vascular space into lung water and alveolar fluid. P-450 inhibitors also prevented the increase in lung tissue levels of thiobarbituric acid reactive products in the model. P-450 inhibitors did not block enhanced O2-. generation by ischemic reperfused lungs, measured by in vivo reduction of succinylated ferricytochrome c in lung perfusate, but did prevent the increase in non-protein-bound low molecular weight chelates of iron after reperfusion. Thus, cytochrome P-450 enzymes are not likely a major source of enhanced O2-. generation, but serve as an important source of iron in mediating oxidant injury to the rabbit lung during reperfusion. These results suggest an important role of cytochrome P-450 in reperfusion injury to the lung and suggest potential new therapies for the disorder.
authors.affiliation: Division of Pediatric Critical Care, University of Tennessee, Memphis.
authors.forename: G K
authors.initials: GK
authors.lastname: Bysani
authors.forename: T P
authors.initials: TP
authors.lastname: Kennedy
authors.forename: N
authors.initials: N
authors.lastname: Ky
authors.forename: N V
authors.initials: NV
authors.lastname: Rao
authors.forename: C A
authors.initials: CA
authors.lastname: Blaze
authors.forename: J R
authors.initials: JR
authors.lastname: Hoidal
mesh_terms: D000818:Animals; D002199:Capillary Permeability / Q000187:drug effects; D002927:Cimetidine / Q000494:pharmacology; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D007501:Iron / Q000378:metabolism; D007511:Ischemia; D008168:Lung / Q000098:blood supply / Q000201:enzymology* / Q000473:pathology; D008730:Methoxsalen / Q000494:pharmacology; D010882:Piperonyl Butoxide / Q000494:pharmacology; D011817:Rabbits; D015427:Reperfusion Injury / Q000201:enzymology*; D013481:Superoxides / Q000378:metabolism; D013858:Thiobarbiturates / Q000378:metabolism
chemical_list: D013858:Thiobarbiturates; D013481:Superoxides; D002927:Cimetidine; D003577:Cytochrome P-450 Enzyme System; D007501:Iron; D010882:Piperonyl Butoxide; C029684:thiobarbituric acid; D008730:Methoxsalen